Growing Demand Drives TactoTek Expansion

New location delivers increased production capacity, purpose-built facility for all IMSE manufacturing processes, and room to grow

OULU, FINLAND (11 July 2017) – Today, TactoTek announced the opening of its new manufacturing and corporate headquarters facilities in Oulu, Finland, initiating a new phase of company growth.

“In early 2016, TactoTek’s project pipeline began growing dramatically and foreshadowed additional production capacity requirements and staffing needs, so we started evaluating alternatives for larger facilities,” noted Jussi Harvela, CEO.

“The new location is purpose-built for manufacturing injection molded structural electronics (IMSE),” emphasized Marko Suo-Anttila, SVP Engineering. “It uniquely contains all production steps of the IMSE manufacturing process, including printing decoration and electronics, surface mounting electronic components, high pressure thermoforming, and injection molding. And, our ISO 7 classification clean room facilities support demanding quality and consistency requirements.”

With its multi-disciplinary engineering teams, TactoTek collaborates with customers to adapt their traditional electronics designs into IMSE solutions. The company produces proofs-of-concepts and prototypes to refine product design and electronic functionality, and define the materials stack and processing parameters. TactoTek’s vertical integration enables rapid iterations to quickly optimize customer designs for mass production. Mass production is performed by TactoTek or a licensed manufacturer.

The European Regional Development Fund and the European Union’s Horizon 2020 Research and Innovation Programme have subsidized TactoTek production equipment and infrastructure.

– – –

Press release in Finnish language can be found here.

– – –

More information for media:

Company info and contact details here.
Pictures and brand assets here.

euThis project has received funding from the European Union’s
Horizon 2020 Research and Innovation Programme
under grant agreement No 725076